LCA-1 research is getting a boost from Genzyme with a $900,000 grant to pursue gene therapy. Dr. Shannon Boye has had success with animals in the lab and is looking to take her research to the next step. She is focusing primarily on the GUCY2D gene.
Researchers are using 3D printers to create artificial retinal nerve cells. They hope this will lead to using this to replace damaged retinal cells and ultimately cure retinal blindness.
My Retina Tracker is a resource from the Foundation Fighting Blindness that lets individuals manage their information around their retina disease, while researchers can curate the information to further treatment of those diseases.
Researchers are developing an oral medicine that improves visual ability in patients with LCA from the RPE65 or LRAT genes. This is very exciting news!
Researchers at the Nuffield Laboratory of Ophthalmology at the University of Oxford in the U.K. are treating Choroideremia (CHM) with gene therapy. This treatment can be used to treat many genetic disorders that cause blindness, including age-related macular degeneration.